The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: emend     Quarter: 2016Q3

Total Records: 233     Number of Pages: 12

DRUGNAME PT EventCount
EMEND Pulmonary toxicity 1
EMEND Rash erythematous 1
EMEND Recurrent cancer 1
EMEND Renal disorder 1
EMEND Respiration abnormal 1
EMEND Seizure 1
EMEND Skin warm 1
EMEND Stevens-Johnson syndrome 1
EMEND Stridor 1
EMEND Terminal state 1
EMEND Toxicity to various agents 1
EMEND Vein disorder 1
EMEND Wheezing 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Abdominal pain 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Cerebrovascular accident 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Colon cancer 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Depressed level of consciousness 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Diarrhoea 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Dizziness 1
EMEND (FOSAPREPITANT DIMEGLUMINE) Drug ineffective 1

Total Records: 233     Number of Pages: 12